DE69230798D1 - Rekombinante immuntoxine - Google Patents

Rekombinante immuntoxine

Info

Publication number
DE69230798D1
DE69230798D1 DE69230798T DE69230798T DE69230798D1 DE 69230798 D1 DE69230798 D1 DE 69230798D1 DE 69230798 T DE69230798 T DE 69230798T DE 69230798 T DE69230798 T DE 69230798T DE 69230798 D1 DE69230798 D1 DE 69230798D1
Authority
DE
Germany
Prior art keywords
recombinant
immuntoxine
relates
immunotoxins
pe38kdel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230798T
Other languages
English (en)
Other versions
DE69230798T2 (de
Inventor
Ira Pastan
Mark Willingham
David Fitzgerald
Uli Brinkmann
Lee Pai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE69230798D1 publication Critical patent/DE69230798D1/de
Publication of DE69230798T2 publication Critical patent/DE69230798T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69230798T 1991-09-30 1992-09-29 Rekombinante immuntoxine Expired - Fee Related DE69230798T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76733191A 1991-09-30 1991-09-30
PCT/US1992/008257 WO1993007286A1 (en) 1991-09-30 1992-09-29 Recombinant immunotoxins

Publications (2)

Publication Number Publication Date
DE69230798D1 true DE69230798D1 (de) 2000-04-20
DE69230798T2 DE69230798T2 (de) 2000-08-03

Family

ID=25079156

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230798T Expired - Fee Related DE69230798T2 (de) 1991-09-30 1992-09-29 Rekombinante immuntoxine

Country Status (8)

Country Link
EP (1) EP0610286B1 (de)
JP (1) JP3512795B2 (de)
AT (1) ATE190659T1 (de)
AU (1) AU675413B2 (de)
CA (1) CA2120153C (de)
DE (1) DE69230798T2 (de)
DK (1) DK0610286T3 (de)
WO (1) WO1993007286A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981726A (en) * 1990-10-12 1999-11-09 The United States Of America As Represented By The Department Of Health And Human Services Chimeric and mutationally stabilized tumor-specific B1, B3 and B5 antibody fragments; immunotoxic fusion proteins; and uses thereof
US5608039A (en) * 1990-10-12 1997-03-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Single chain B3 antibody fusion proteins and their uses
US5889157A (en) * 1990-10-12 1999-03-30 The United States Of America As Represented By The Department Of Health And Human Services Humanized B3 antibody fragments, fusion proteins, and uses thereof
ATE151113T1 (de) * 1992-01-23 1997-04-15 Merck Patent Gmbh Fusionsproteine von monomeren und dimeren von antikörperfragmenten
EP0651805B1 (de) * 1992-07-17 2006-12-13 Dana Farber Cancer Institute Method eder intrazellularen bindung von zielgerichteten molekülen
US5747654A (en) * 1993-06-14 1998-05-05 The United States Of America As Represented By The Department Of Health And Human Services Recombinant disulfide-stabilized polypeptide fragments having binding specificity
FR2706486B1 (fr) * 1993-06-16 1995-09-01 Rhone Poulenc Rorer Sa Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques.
US5851829A (en) * 1993-07-16 1998-12-22 Dana-Farber Cancer Institute Method of intracellular binding of target molecules
AU717611B2 (en) * 1994-10-28 2000-03-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Tumor-specific antibody fragments, fusion proteins, and uses thereof
WO1996038571A2 (en) * 1995-05-31 1996-12-05 Regents Of The University Of Minnesota Recombinant polypeptide cytotoxins for cancer treatment
DE69629580D1 (de) * 1995-10-13 2003-09-25 Us Gov Health & Human Serv Immunotoxin enthaltend ein disulfid-stabilisiertes antikörperfragment
EP0912738B1 (de) 1996-05-22 2008-07-30 Viventia Biotech Inc. Antigenbindungsfragmente die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
NZ335864A (en) 1996-11-06 2001-09-28 Univ California Isolated tumor necrosis factor receptor releasing enzyme (TRRE), compositions comprising the enzyme and methods of the use in modulation of TNF levels
US7115722B1 (en) 1997-05-22 2006-10-03 Viventia Biotech, Inc. Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
JP3471006B2 (ja) 1998-05-20 2003-11-25 中外製薬株式会社 新規な遺伝子クローニング方法
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
EP1969165A4 (de) * 2005-12-23 2010-05-19 Viventia Biotech Inc Verfahren zum generieren und screenen von fusionsproteinbibliotheken und verwendungen davon
US8932586B2 (en) 2011-09-06 2015-01-13 Intrexon Corporation Modified forms of Pseudomonas exotoxin A

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69027210T2 (de) * 1989-04-21 1997-01-23 Us Health Rekombinantes antikörper-toxin-fusion-protein

Also Published As

Publication number Publication date
JP3512795B2 (ja) 2004-03-31
JPH07502643A (ja) 1995-03-23
EP0610286A4 (en) 1995-10-25
EP0610286A1 (de) 1994-08-17
EP0610286B1 (de) 2000-03-15
ATE190659T1 (de) 2000-04-15
CA2120153A1 (en) 1993-04-15
WO1993007286A1 (en) 1993-04-15
DK0610286T3 (da) 2000-07-17
AU2779892A (en) 1993-05-03
DE69230798T2 (de) 2000-08-03
AU675413B2 (en) 1997-02-06
CA2120153C (en) 2006-06-06

Similar Documents

Publication Publication Date Title
DE69230798T2 (de) Rekombinante immuntoxine
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
FI844510L (fi) Ensym-resistenta immunsystemet modulerande peptider.
ES2066603T3 (es) Fungicidas de 3-difluorometilpirazolcarboxamida.
BR0112111A (pt) Realce de respostas imunes mediadas por proteìna de fusão de anticorpo-citocina por tratamento combinado com agentes de realce de captação de imunocitocina
ES8602768A1 (es) Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
YU17092A (sh) Derivati 2,4-diaminohinazolina
DE122006000010I2 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in derBehandlung von kardiovaskularen Krankheiten
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
DK0668769T3 (da) Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse
EP0552296A4 (en) Mouse monoclonal antibodies
DE69434384D1 (de) Metalkomplexbildner
ATE199167T1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
DK0563085T3 (da) Hidtil ukendte præparater
EP0311616A4 (de) Kombination von gammainterferonen und antientzündungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.
DE69106361T2 (de) Einschlusskomplex von nimesulide mit cyclodextrinen.
DE69321585T2 (de) PArENTERALE LÖSUNGEN ENTHALTEND 3-DIALKYLAMINOETHOXYBENZOYLBENZOFURANE
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
SE8900564D0 (sv) Novel medicinal use
IT9047812A0 (it) Complesso per la stabilizzazione del rachide dorso-lombo-sacrale e relativo metodo di stabilizzazione.
ITMI911597A1 (it) Composizione di trattamento di acque di rifiuto da destinare al riciclo, e procedimento di riciclo di acque di rifiuto che utilizza questa composizione.
ITFE930013U1 (it) Bacchette orientali meccanizzate.
IT8459312V0 (it) Massaggiatore manuale in fibra intrecciata di tipo perfezionato.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee